| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.27 | 7e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.092 | 0.08 |